Fund profile / United Kingdom

Epidarex Capital Fund IV

Stage
Seed
Fund size
€122M
Focus
Biotech
Signals
Published
Share
N°01 / About

About Epidarex Capital Fund IV

Transatlantic life-science fund secured $145M first close for Fund IV to fuel early-stage drug discovery and healthtech startups in the UK and US.

N°02 / Thesis

Investment Focus

Location / RegionUnited Kingdom
Funding StageSeed
Industry Focus
Biotech

Investor Signals Profile

active

Sweet Spot

Rare disease biotech founders with clinical validation

immunology
rare disease
nephrology
biopharma
complement biology
oncolytic immunotherapy
oncology
cardiometabolic
inflammation
peripheral artery disease

Bullish Signals

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Contrarian Signals

No contrarian signals recorded.

Founder Do's

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Founder Don'ts

Signal text is part of a paid plan
Signal text is part of a paid plan

27 signals on Epidarex Capital Fund IV

16 bullish · 5 pitch do's · 2 don'ts · 4 GP profiles, each with its source. From €9/month, cancel anytime.

Michael's Network

Facts

Fund Overview

Fund Size€122M
Saves0
People

Key People

Sinclair Dunlop

Kyparissia SirinakisFounding Partner
Elizabeth RoperManaging Partner
Peter FinanManaging Partner
Lori Krim GoughPartner
N°04 / See also

Related Funds

Seaya Nova

Fund size€600M
Location
United Kingdom
Stage
Series B
Focus
Series B
Location
United Kingdom
Stage
Series B
Focus
Space, Ai Ml, Fintech, Deep Tech
Series B
Space
Ai Ml
Fintech
Deep Tech
Location
United Kingdom
Stage
Series A
Focus
Saas
Manager
Nick Kaiser, Jan Olivier Fillols, Eter Spasov
Series A
Saas
Connect your agent Free to start. No key, no signup.